Pulmonx Corporation
LUNG
$4.52
-$0.27-5.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.13% | 5.07% | 5.37% | 13.31% | 2.77% |
| Total Depreciation and Amortization | 2.44% | -202.17% | 193.40% | -3.20% | -25.65% |
| Total Amortization of Deferred Charges | -15.38% | 6,138.46% | 7,658.33% | 60.00% | 30.00% |
| Total Other Non-Cash Items | -3.78% | -17.14% | -4.54% | 14.56% | 13.56% |
| Change in Net Operating Assets | 286.97% | 180.80% | -11.29% | -78.45% | 48.28% |
| Cash from Operations | 20.35% | 16.04% | 26.88% | 6.71% | 13.84% |
| Capital Expenditure | 44.50% | 15.45% | -768.52% | -639.34% | -13.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 654.91% | 384.58% | 51.78% | -423.78% | -363.70% |
| Cash from Investing | 610.60% | 583.99% | -2.71% | -536.76% | -278.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.26% | -- | 2.13% | -- | -9.30% |
| Issuance of Common Stock | 73.44% | -19.61% | -82.73% | 20.00% | -66.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 264.71% | -19.61% | -123.91% | -95.83% | -74.63% |
| Foreign Exchange rate Adjustments | 191.90% | -158.91% | -319.05% | 128.57% | -5.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.61% | 97.80% | 22.33% | -254.42% | -6.85% |